Study: Tube Placement May Be Unnecessary for Treating Upper GI Bleeds

Contact: Heather Woolwine
843-792-7669
woolwinh@musc.edu

Feb. 7, 2017

CHARLESTON, SC – A study published in the February issue of General Internal Medicine suggests that for many of the millions of patients treated annually in hospitals for upper gastrointestinal (GI) bleeding, there is little value in placing a nasogastric (NG) tube in patients to determine the source of that bleeding or size of a lesion.

Study authors, including Don Rockey, M.D., Medical of University of South Carolina (MUSC) Department of Medicine chairman and professor of gastroenterology, position the research as improving patient care by doing less when possible, in terms of procedures or treatments that don’t provide significant benefit to patients and are costly and uncomfortable.

“Placing a tube through the nose and down into the stomach makes sense if we are talking about delivering nutrition to a patient or to get an idea of what is in someone’s stomach, but the value of placing this tube for patients who have an upper GI bleed has been unclear,” Rockey said. “Our goal was to examine that value, and our results suggest that for millions of patients with an upper GI bleed, placing this tube had little clinical benefit, and produces unnecessary cost and discomfort for all involved. If it doesn’t help the patient or the clinician trying to diagnose the cause of this kind of bleed, we don’t need it as a standard of care when there is no value.”

The single-blind, randomized, prospective, non-inferiority study compared NG placement (with aspiration and lavage) to no NG placement (control), and demonstrated that NG tube placement in patients with typical upper GI bleeding had no impact on outcomes. In addition, the placement of NG tubes was often unsuccessful or associated with patient discomfort.

About MUSC

Founded in 1824 in Charleston, MUSC is the state’s only comprehensive academic health system, with a mission to preserve and optimize human life in South Carolina through education, research and patient care. Each year, MUSC educates over 3,100 students in six colleges and trains 950+ residents and fellows across its health system. MUSC leads the state in federal and National Institutes of Health and research funding. For information on our academic programs, visit musc.edu.

As the health care system of the Medical University of South Carolina, MUSC Health is dedicated to delivering the highest-quality and safest patient care while educating and training generations of outstanding health care providers and leaders to serve the people of South Carolina and beyond. In 2024, for the 10th consecutive year, U.S. News & World Report named MUSC Health University Medical Center in Charleston the No. 1 hospital in South Carolina. To learn more about clinical patient services, visit muschealth.org.

MUSC has a total enterprise annual operating budget of $7.1 billion. The 31,000 MUSC members include world-class faculty, physicians, specialty providers, scientists, contract employees, affiliates and care team members who deliver groundbreaking education, research, and patient care.